1. Home
  2. KNDI vs ZTEK Comparison

KNDI vs ZTEK Comparison

Compare KNDI & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KNDI

Kandi Technologies Group Inc

HOLD

Current Price

$0.83

Market Cap

67.8M

ML Signal

HOLD

Logo Zentek Ltd.

ZTEK

Zentek Ltd.

N/A

Current Price

$0.55

Market Cap

68.8M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
KNDI
ZTEK
Founded
2002
2008
Country
China
Canada
Employees
N/A
N/A
Industry
Auto Manufacturing
Major Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
67.8M
68.8M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
KNDI
ZTEK
Price
$0.83
$0.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
175.6K
66.6K
Earning Date
04-27-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.78
$0.50
52 Week High
$1.77
$1.84

Technical Indicators

Market Signals
Indicator
KNDI
ZTEK
Relative Strength Index (RSI) 38.61 38.71
Support Level $0.81 $0.55
Resistance Level $1.10 $0.75
Average True Range (ATR) 0.07 0.04
MACD -0.01 -0.01
Stochastic Oscillator 18.73 33.33

Price Performance

Historical Comparison
KNDI
ZTEK

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.

About ZTEK Zentek Ltd.

Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.

Share on Social Networks: